Clinical Trials Insight: 700014389

Trial Profile

Clinical Trials Insight: 700014389

Phase of Trial: Phase II

Latest Information Update: 22 Dec 2006

At a glance

  • Drugs Peptide YY 3-36; Peptide YY 3-36
  • Indications Obesity
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Marina Biotech
  • Most Recent Events

    • 22 Dec 2006 Status changed from in progress to completed
    • 17 Aug 2006 The expected completion date for this trial is now 1 Sep 2006.
    • 17 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top